Skip to main content
Erschienen in: Infection 6/2016

28.05.2016 | Case Report

Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient

verfasst von: R. L. Roerdink, C. M. Douw, A. C. A. P. Leenders, R. S. Dekker, M. Dietvorst, C. J. M. Oosterbos, H. T. J. Roerdink, R. W. T. M. Kempen, L. P. A. Bom

Erschienen in: Infection | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

This case study discusses how we diagnosed and treated a patient with a late haematogenous bilateral periprosthetic joint infection (PJI) after total knee arthroplasties caused by Ureaplasma urealyticum. This has never been reported before. We will discuss how we used a PET-CT, synovial fluid cell count, and synovial fluid analysis by 16S rRNA gene sequencing to diagnose this PJI. We will also discuss how we treated this patient to obtain full recovery.
Literatur
1.
Zurück zum Zitat Huotari K, Peltola M, Jämsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86:321–5.CrossRefPubMedPubMedCentral Huotari K, Peltola M, Jämsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015;86:321–5.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærsgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86:326–34.CrossRefPubMedPubMedCentral Gundtoft PH, Overgaard S, Schønheyder HC, Møller JK, Kjærsgaard-Andersen P, Pedersen AB. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop. 2015;86:326–34.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat J Parvizi, T Gehrke. In: Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. 2013. ISBN 978-1-57400-147-1. J Parvizi, T Gehrke. In: Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. 2013. ISBN 978-1-57400-147-1.
4.
Zurück zum Zitat Kumar R, Kumar V, Malhotra R. Potential clinical implication of 18 F-FDG PET/CT in diagnosis of periprosthetic infection and its comparison with 18 F-Fluoride PET/CT. J Med Imaging Radiat Oncol. 2016. doi:10.1111/1754-9485.12444 (Epub ahead of print). Kumar R, Kumar V, Malhotra R. Potential clinical implication of 18 F-FDG PET/CT in diagnosis of periprosthetic infection and its comparison with 18 F-Fluoride PET/CT. J Med Imaging Radiat Oncol. 2016. doi:10.​1111/​1754-9485.​12444 (Epub ahead of print).
5.
Zurück zum Zitat Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H, et al. FDG PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined (111)In-labeled leukocyte/(99 m)Tc-sulfur colloid bone marrow imaging in 88 prostheses. Clin Nucl Med. 2014;39:609–15.CrossRefPubMedPubMedCentral Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H, et al. FDG PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined (111)In-labeled leukocyte/(99 m)Tc-sulfur colloid bone marrow imaging in 88 prostheses. Clin Nucl Med. 2014;39:609–15.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bedair H, Ting N, Jacovides C, Saxena A, Moric M, Parvizi J, Della Valle CJ. The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res. 2011;469:34–40.CrossRefPubMed Bedair H, Ting N, Jacovides C, Saxena A, Moric M, Parvizi J, Della Valle CJ. The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res. 2011;469:34–40.CrossRefPubMed
7.
Zurück zum Zitat Sköldenberg OG, Rysinska AD, Neander G, Muren OH, Ahl TE. Ureaplasma urealyticum infection in total hip arthroplasty leading to revision. J Arthroplasty. 2010;25:11–3.CrossRef Sköldenberg OG, Rysinska AD, Neander G, Muren OH, Ahl TE. Ureaplasma urealyticum infection in total hip arthroplasty leading to revision. J Arthroplasty. 2010;25:11–3.CrossRef
8.
Zurück zum Zitat Dias JM, Costa MM, da Silva JAP, de Queiroz MV. Septic arthritis: patients with or without isolated infectious agents have similar characteristics. Infection. 2014;42:385–91.CrossRef Dias JM, Costa MM, da Silva JAP, de Queiroz MV. Septic arthritis: patients with or without isolated infectious agents have similar characteristics. Infection. 2014;42:385–91.CrossRef
9.
Zurück zum Zitat Lai GG, Lim ST, Tao M, Chan A, Li H, Quek R. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma. Am J Hematol. 2009;84:414–7.CrossRefPubMed Lai GG, Lim ST, Tao M, Chan A, Li H, Quek R. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma. Am J Hematol. 2009;84:414–7.CrossRefPubMed
10.
Zurück zum Zitat Boxer L. How to approach neutropenia. Hematol Educ Progr Am Soc Hematol. 2012;2012:174–82. Boxer L. How to approach neutropenia. Hematol Educ Progr Am Soc Hematol. 2012;2012:174–82.
11.
Zurück zum Zitat Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother. 2005;55:45–50.CrossRefPubMed Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother. 2005;55:45–50.CrossRefPubMed
13.
Zurück zum Zitat Kado R, Sanders G, McCune WJ. Suppression of normal immune responses after treatment with rituximab. Curr Opin Rheumatol. 2016;28:251–8.CrossRefPubMed Kado R, Sanders G, McCune WJ. Suppression of normal immune responses after treatment with rituximab. Curr Opin Rheumatol. 2016;28:251–8.CrossRefPubMed
14.
Zurück zum Zitat Filanovsky K, Miller EB, Sigler E, Berrebi A, Shvidel L. Incidence of profound hypogammaglobulinemia and infection rate in lymphoma patients following the combination of chemotherapy and rituximab. Recent Pat Anticancer Drug Discov. 2016;11:228–35.CrossRefPubMed Filanovsky K, Miller EB, Sigler E, Berrebi A, Shvidel L. Incidence of profound hypogammaglobulinemia and infection rate in lymphoma patients following the combination of chemotherapy and rituximab. Recent Pat Anticancer Drug Discov. 2016;11:228–35.CrossRefPubMed
15.
Zurück zum Zitat Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev. 2009;22:396–414.CrossRefPubMedPubMedCentral Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev. 2009;22:396–414.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Achermann Y, Stasch P, Preiss S, Lucke K, Vogt M. Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee. Infection. 2014;42:511–9.CrossRefPubMed Achermann Y, Stasch P, Preiss S, Lucke K, Vogt M. Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee. Infection. 2014;42:511–9.CrossRefPubMed
17.
Zurück zum Zitat Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23:77–9.CrossRefPubMed Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23:77–9.CrossRefPubMed
Metadaten
Titel
Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient
verfasst von
R. L. Roerdink
C. M. Douw
A. C. A. P. Leenders
R. S. Dekker
M. Dietvorst
C. J. M. Oosterbos
H. T. J. Roerdink
R. W. T. M. Kempen
L. P. A. Bom
Publikationsdatum
28.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0912-0

Weitere Artikel der Ausgabe 6/2016

Infection 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.